Doximity shares surged more than 43% on August 6, 2026, after the company reported fiscal first-quarter 2027 earnings driven by strong adoption of its AI tools. Nearly 300,000 quarterly active users are now using its AI suite, with almost half of US doctors at client hospitals engaging with its workflow and scheduling tools. The company’s market capitalization stood at $3.7 billion before the report, having dropped 50% year-to-date prior to the announcement. One analyst cautioned about a potential cannibalization risk to the legacy business model based on medical networking and advertising, if physicians increasingly prioritize AI-powered clinical tools over traditional professional networking features.
Source: Read the original article
